Advances in Biopharmaceutical Drug Design and Development
American Journal of Pharmaceutics · 30.06.2022 · 3 (3) · 1-17
DOI: 10.71465/ajph2168 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Pharmaceutics, online erschienen am 30.06.2022. Verfasst von Dr. John Smith. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The field of biopharmaceutical drug design and development has experienced significant advancements in recent years, driven by innovations in molecular biology, biotechnology, and computational sciences. These developments have led to the creation of more targeted, effective, and personalized therapeutics. This article explores the key innovations in biopharmaceuticals, with a focus on new drug design approaches, biotechnological advancements, and regulatory challenges. The integration of nanotechnology, gene therapies, and monoclonal antibodies into clinical practice has revolutionized the treatment of various diseases, including cancer, autoimmune disorders, and genetic conditions. Furthermore, we discuss the role of personalized medicine in improving therapeutic outcomes and reducing side effects. Despite these advancements, challenges remain in manufacturing, regulatory approval, and cost-effectiveness, which continue to shape the future of biopharmaceutical development.
Zitieren
APA
Smith, D. J. (2022). Advances in Biopharmaceutical Drug Design and Development. American Journal of Pharmaceutics, 3(3), 1-17. https://doi.org/10.71465/ajph2168
Vancouver
Smith DJ. Advances in Biopharmaceutical Drug Design and Development. American Journal of Pharmaceutics. 2022;3(3):1-17. doi:10.71465/ajph2168
BibTeX
@article{Smith2022,
author = {Smith, Dr. John},
title = {Advances in Biopharmaceutical Drug Design and Development},
journal = {American Journal of Pharmaceutics},
year = {2022},
volume = {3},
number = {3},
pages = {1--17},
doi = {10.71465/ajph2168}
}
EUVIMED